Meryl Braun v. HHS - Influenza, Guillain-Barré Syndrome (GBS) and Systemic Lupus Erythematosus (SLE) (2018)
Case summary [AI summaries can sometimes make mistakes]
On September 2, 2016, Meryl Braun filed a claim under the National Vaccine Injury Compensation Program, alleging that an influenza vaccination received on September 11, 2013, caused her to develop Guillain-Barré Syndrome (GBS). Initially, she claimed GBS onset approximately four months after the vaccination.
The respondent argued that this timeframe was too long for a vaccine-related GBS claim, as the Vaccine Injury Table presumes causation for GBS onset within 3 to 42 days after a flu vaccination. Petitioner later amended her claim, alleging that the flu vaccination caused Systemic Lupus Erythematosus (SLE), with GBS being a component of this broader autoimmune condition.
She presented expert testimony from Dr. Arthur Brawer, a rheumatologist, who opined that the vaccination induced SLE through molecular mimicry.
Dr. Brawer cited symptoms such as fatigue, headache with visual aura (fortification spectra), hemolytic anemia, a miscarriage, and joint inflammation as evidence of SLE.
He also stated that the SLE began within 24 hours of the vaccination. Respondent presented expert testimony from Dr.
Mehrdad Matloubian, also a rheumatologist, who disputed both the SLE diagnosis and the alleged causation. Dr.
Matloubian argued that the contemporaneous medical records did not support the early onset of symptoms claimed by Dr. Brawer and petitioner, that many of the claimed symptoms were non-specific or consistent with residual GBS, and that petitioner did not meet the diagnostic criteria for SLE.
He noted that the petitioner's GBS onset was documented in mid-January 2014, approximately four months after the vaccination, and that her later accounts of symptom onset diverged from the contemporaneous medical records and her original petition. The Special Master, Thomas L.
Gowen, found that petitioner failed to establish by a preponderance of the evidence that the flu vaccination caused her GBS, given the four-month delay, which was well outside the Table's timeframe and not supported by medical literature for later onset. Furthermore, the Special Master determined that petitioner had not submitted sufficient evidence to rebut the contemporaneous medical records and establish that her GBS was part of a larger injury, SLE, that began within 24 hours of the vaccination.
The Special Master found the later accounts of symptom onset inconsistent with the medical records and the original petition, and therefore, petitioner's claim for compensation was denied and dismissed.
Theory of causation
Petitioner Meryl Braun, age 30, received an influenza vaccination on September 11, 2013. She initially alleged Guillain-Barré Syndrome (GBS) with onset approximately four months later, which is outside the Vaccine Injury Table's timeframe for presumed causation (3-42 days). Petitioner later amended her claim to allege Systemic Lupus Erythematosus (SLE) caused by the vaccination, with GBS as a component. Petitioner's expert, Dr. Arthur Brawer, opined that the flu vaccination caused SLE through molecular mimicry, citing symptoms including fatigue within 24 hours of vaccination, fortification spectra, hemolytic anemia, joint inflammation, and a miscarriage. Respondent's expert, Dr. Mehrdad Matloubian, disputed the SLE diagnosis and causation, arguing that contemporaneous medical records did not support the alleged early onset of symptoms and that many symptoms were non-specific or consistent with residual GBS. The Special Master, Thomas L. Gowen, found that the petitioner failed to establish by a preponderance of the evidence that the flu vaccination caused her GBS due to the remote onset, and further found that the petitioner's later accounts of symptom onset were inconsistent with the contemporaneous medical records and her original petition, thus failing to establish SLE causation. The claim was denied. Attorneys for petitioner were Martin J. Rubenstein and Lisa A. Watts for respondent. Decision date: May 25, 2018.
Source PDFs
USCOURTS-cofc-1_16-vv-01098